| GENERIC NAME | This data is not available for free |
| INDICATION'S | This data is not available for free |
| MECHANISM OF ACTION | This data is not available for free |
| OBSERVATION'S |
Patients in the EYLEA 2mg every eight week group achieved visual acuity gains similar to ranibizumab with 5 fewer injections, on average, over two years Patients who required the most intense therapy received, on average, 1.4 fewer injections in the EYLEA 2mg every eight week group compared to ranibizumab in the second year |
| STATUS |
CA>Approved USA>Approved |
| UPDATE | 11.12.13 |
| COMPANY | This data is not available for free |
| LICENSEE | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |